News

Home - Archive by category: News

Solubilization of an hydrophobic API for anti-cancer treatment

Poor water solubility is one of the most significant barrier limiting drug development. Indeed, more than 40% of compounds identified through combinatorial screening programs display poor aqueous solubility, which is associated with poor bioavailability, suboptimal dosing, etc. Adjuvatis uses a safe-by-design technology that allows formulation of APIs with little or no solubility. Adjuvatis develops biocompatible[...]
Read More

FASTCURE: a consortium of experts to respond to the epidemic COVID-19 coronavirus outbreak

FASTCURE is a consortium of experts for screening, identification and formulation of chemical compounds to combat SARS-CoV-2. Drug repurposing can be a key strategy to fight against pathogens, especially when it comes as a rapid response to an emerging pathogen such as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) identified in Wuhan, China in January[...]
Read More

Funding awarded for an Innovative Training Network, DRIVE!

Adjuvatis is hiring a PhD Student for 3 years starting at May 2018 The European Innovative Training Network DRIVE (Driving next generation autophagy researchers towards translation) officially starts on November 1st, 2017! Adjuvatis is one of the 15 beneficiaries of this project and is hiring a PhD Student to work on the project: Design and[...]
Read More